azacitidine has been researched along with Pleural Effusion in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, L; Hu, L; Hu, M; Zheng, B | 1 |
| Goo, K; Roswarski, J; Uy, R | 1 |
| Fernández-Sojo, J; Oliveras Vilà , T; Ribera, JM; Vives, S | 1 |
| Chan, CH; Chen, CC; Gau, JP; Lee, KD; Lin, JT; Lu, CH; You, JY | 1 |
1 review(s) available for azacitidine and Pleural Effusion
| Article | Year |
|---|---|
Chronic myelomonocytic leukemia (CMML)-0 with pleural effusion as first manifestation: A case report.
Topics: Adult; Antineoplastic Agents; Azacitidine; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Leukemia, Myelomonocytic, Chronic; Lung Neoplasms; Pleural Effusion; Tomography, X-Ray Computed | 2020 |
3 other study(ies) available for azacitidine and Pleural Effusion
| Article | Year |
|---|---|
Azacitidine-associated pleuropericardial effusion in myelodysplastic syndrome: A case report.
Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Humans; Male; Myelodysplastic Syndromes; Pericardial Effusion; Pleural Effusion | 2019 |
[Exudative pericardial effusion and oligoarthritis in a patient newly diagnosed with myelodysplastic syndrome].
Topics: Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Arthritis; Azacitidine; Cytarabine; Disease Progression; Etoposide; Fatal Outcome; Hepatomegaly; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Middle Aged; Pericardial Effusion; Pleural Effusion; Serositis | 2014 |
Decitabine-induced effusions.
Topics: Azacitidine; Decitabine; Female; Humans; Middle Aged; Myelodysplastic Syndromes; Pleural Effusion | 2009 |